Nova Publishers
My Account Nova Publishers Shopping Cart
HomeBooksSeriesJournalsReference CollectionseBooksInformationSalesImprintsFor Authors
            
  Top » Catalog » Books » Biology » Physiology » Aerobic Exercise: Health Benefits, Types and Common Misconceptions Chapters » My Account  |  Cart Contents  |  Checkout   
Quick Find
  
Use keywords to find the product you are looking for.
Advanced Search
What's New? more
Artificial Intelligence Driven by a General Neural Simulation System (Genesis)
$279.00
Shopping Cart more
0 items
Information
Shipping & Returns
Privacy Notice
Conditions of Use
Contact Us
Notifications more
NotificationsNotify me of updates to Exercise Intervention in Treatment-Resistant Major Depressive Disorder: Benefits of Accelerometer Monitoring (pp. 113-136)
Tell A Friend
 
Tell someone you know about this product.
Exercise Intervention in Treatment-Resistant Major Depressive Disorder: Benefits of Accelerometer Monitoring (pp. 113-136) $0.00
Authors:  (Jorge Mota-Pereira, Jose Carlos Ribeiro, Daniela Fonte, Serafim Carvalho, Joaquim Ramos, Jorge Silverio, Psychosocial Rehabilitation Department, Hospital Magalhaes Lemos, Porto, Portugal, and others)
Abstract:
Although there are several reports on the benefits of exercise on Major Depressive
Disorder, none has monitored these exercise programs with accelerometers. We have
conducted a 12 week home based moderate intensity exercise program in 33 treatmentresistant
Major Depressive Disorder patients and, based on accelerometer data,
determined compliance, exercise patterns and relationship between time spent in MVPA,
response to treatment and Quality of Life. Patients were diagnosed according to DSM-IV
criteria, and, from 150 initially screened, 33 met study criteria and were included. Four
patients were excluded due to non-compliance/drop-out, thus a total of 29 patients
finished the study. Patients were randomized either to a moderate intensity exercise
program, which consisted of 30-45 min/day walks, 5 days/week, for 12 weeks, plus usual
pharmacotherapy (N=22) or regular daily activities plus usual pharmacotherapy (N=11).
All participants wore an ActiGraph® GT1M accelerometer during the 12 weeks.
Moderate to very vigorous physical activity (MVPA), HAMD17, BDI, GAF, CGI-S,
WHOQOL-Bref and SF-36 were assessed. Results show a trend for increasing time spent
in MVPA from no response to response and remission (p = 0.028), and medium to strong
correlations between time spent in MVPA and better depression and functioning
parameters. There was also a trend for increasing time spent in MVPA and improvement
of some QoL domains, namely WHOQOL-Bref Physical domain and SF-36 Physical
Functioning and General Health Domains (p < 0.05). Participants showed preference for
exercising on weekdays and on specific periods of the day (p < 0.05). Therefore, we
suggest that future implementation of effective exercise augmentation therapy programs
in MDD patients should consider objective measures that allow the quantification of
exercise and assessment of exercise patterns. 


Available Options:
Version:

  Open Access item.
  Click below PDF icon for free download.

  

This is an Open Access item. Click above PDF icon for free download.
Special Focus Titles
01.Looking Upwards: Stars in Ancient and Medieval Cultures
02.Iranians in the Minds of Americans
03.Gleanings in the West of Ireland: Annotated Edition
04.Cystic Tumors of the Pancreas
05.Normalization, Enjoyment and Bodies/Emotions: Argentine Sensibilities
06.Genius, Creativity and Madness
07.The New Age of the Confederacy: Trump and the Surge in National Disunity
08.Social Media: Practices, Uses and Global Impact
09.The Wetlands of India
10.Geomagnetosphere and Coupling Phenomena, Volume I: Solar Wind/IMF Coupling with Geomagnetosphere/Ionosphere
11.Turbochargers and Turbocharging: Advancements, Applications and Research
12.Completion and Unification of Quantum Mechanics with Einstein's GR Ideas, Part II: Unification with GR

Nova Science Publishers
© Copyright 2004 - 2017

Exercise Intervention in Treatment-Resistant Major Depressive Disorder: Benefits of Accelerometer Monitoring (pp. 113-136)